X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Strides Arcolab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs TEVA PHARMA (Israel) - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES SHASUN LTD   TEVA PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
TEVA PHARMA
Dec-13
STRIDES SHASUN LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2752,709-   
Low Rs9182,353-   
Sales per share (Unadj.) Rs389.61,554.5-  
Earnings per share (Unadj.) Rs28.097.1-  
Cash flow per share (Unadj.) Rs48.9222.8-  
Dividends per share (Unadj.) Rs4.5085.01-  
Dividend yield (eoy) %0.43.4 12.2%  
Book value per share (Unadj.) Rs303.11,726.7-  
Shares outstanding (eoy) m89.42848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.6 172.9%   
Avg P/E ratio x39.226.1 150.4%  
P/CF ratio (eoy) x22.411.4 197.4%  
Price / Book Value ratio x3.61.5 246.8%  
Dividend payout %16.187.5 18.4%   
Avg Mkt Cap Rs m98,0362,146,042 4.6%   
No. of employees `0005.844.9 12.9%   
Total wages/salary Rs m5,8810-   
Avg. sales/employee Rs Th6,005.929,328.6 20.5%   
Avg. wages/employee Rs Th1,014.00-   
Avg. net profit/employee Rs Th431.21,832.1 23.5%   
INCOME DATA
Net Sales Rs m34,8341,318,175 2.6%  
Other income Rs m1,6860-   
Total revenues Rs m36,5201,318,175 2.8%   
Gross profit Rs m6,428360,983 1.8%  
Depreciation Rs m1,872106,549 1.8%   
Interest Rs m2,26925,891 8.8%   
Profit before tax Rs m3,973228,543 1.7%   
Minority Interest Rs m01,038 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,006-150,026 0.7%   
Tax Rs m470-2,790 -16.8%   
Profit after tax Rs m2,50182,345 3.0%  
Gross profit margin %18.527.4 67.4%  
Effective tax rate %11.8-1.2 -968.9%   
Net profit margin %7.26.2 114.9%  
BALANCE SHEET DATA
Current assets Rs m38,165890,291 4.3%   
Current liabilities Rs m30,402776,409 3.9%   
Net working cap to sales %22.38.6 258.0%  
Current ratio x1.31.1 109.5%  
Inventory Days Days7791 85.2%  
Debtors Days Days10496 108.9%  
Net fixed assets Rs m37,639430,545 8.7%   
Share capital Rs m8943,245 27.6%   
"Free" reserves Rs m26,2100-   
Net worth Rs m27,1051,464,243 1.9%   
Long term debt Rs m16,377674,012 2.4%   
Total assets Rs m81,1683,012,453 2.7%  
Interest coverage x2.89.8 28.0%   
Debt to equity ratio x0.60.5 131.3%  
Sales to assets ratio x0.40.4 98.1%   
Return on assets %5.93.6 163.6%  
Return on equity %9.25.6 164.1%  
Return on capital %12.14.9 244.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,3890-   
CASH FLOW
From Operations Rs m2,881210,049 1.4%  
From Investments Rs m-7,051-74,429 9.5%  
From Financial Activity Rs m3,382-251,968 -1.3%  
Net Cashflow Rs m-788-116,348 0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.89 Rs / USD

Compare STRIDES SHASUN LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare STRIDES SHASUN LTD With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC LTD  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

Indian Indices Trade Strong; Metal, Pharma Stocks Lead Gains(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading above the dotted line.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 23, 2018 01:57 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS